For over a hundred years, the specter of a schizophrenia diagnosis has frightened patients and their families. Yet it confers no useful meaning for treatment or prognosis.
A 2026 informational consumer research report examining FocusMax cognitive support marketing claims, ingredient-level research context, proprietary blend transparency, pricing disclosures, and verific ...
Memopezil is at the center of a rapidly growing conversation about cognitive health in 2026, as consumer interest in brain support has reached an all-time high, with search volume for terms like ...
Many of us would like to see ourselves as independent thinkers, capable of being reflective, intellectually curious, and aware. This post aims to help you see your strengths and areas where you could ...
Adjuvant therapy with durvalumab (Imfinzi) and tremelimumab-actl (Imjudo) in patients with resected RCC was associated with early reductions in patient-reported quality of life (QoL), according to ...
Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and ...
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated ...
Patients with resected renal cell carcinoma (RCC) receiving adjuvant durvalumab (Imfinzi) plus tremelimumab-actl (Imjudo) experienced early reductions in patient-reported quality of life (QoL), ...
A 2026 informational consumer evaluation of AudiLeaf's ear health marketing claims, proprietary herbal blend ingredient ...
Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...
Adults age 65 and older who completed five to six weeks of cognitive speed training and who had follow-up sessions about one to three years later were less likely to be diagnosed with dementia, ...
Credit: Getty Images Early recognition of cognitive decline in primary care allows for improved management of mild cognitive impairment and dementia in aging populations. As the US population ages, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results